The global, first-in-human, open-label trial will assess the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of TRI-611
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
India faces a significant and growing burden of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease
A disinfectant credited with helping contain some of the world’s most dangerous livestock diseases is marking a major milestone
The study included four independent genetic substudies targeting obesity caused by heterozygous variants in the POMC/PCSK1, LEPR, SRC1 (NCOA1), and SH2B1 genes
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The approval of Cosentyx represents an important advancement for younger HS patients who have had limited treatment options
The deal also includes upfront licensing fees and milestone-based payments from Lupin to Zydus
At the center of the announcement are two late-breaking studies that could reshape treatment approaches for patients with high cholesterol and a complex form of heart failure
Subscribe To Our Newsletter & Stay Updated
